Current Net Margin
—
Inhibikase Therapeutics, Inc. currently has a net profit margin of —.
Financial Fundamentals
IKT • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.00 | -0.01 | — | — |
| 2025-09-30 | 0.00 | -0.01 | — | — |
| 2025-06-30 | 0.00 | -0.01 | — | — |
| 2025-03-31 | 0.00 | -0.01 | — | — |
| 2024-12-31 | 0.00 | -0.01 | — | — |
| 2024-09-30 | 0.00 | -0.01 | — | — |
| 2024-06-30 | 0.00 | -0.00 | — | — |
| 2024-03-31 | 0.00 | -0.00 | — | — |
| 2023-12-31 | 0.00 | -0.00 | -417794000.00% | ▼41778822489 |
| 2023-09-30 | 0.00 | -0.00 | -5775.11% | ▼81165 |
| 2023-06-30 | 0.00 | -0.01 | -4963.46% | ▲197668 |
| 2023-03-31 | 0.00 | -0.00 | -6940.14% | ▼20847 |
| 2022-12-31 | 0.00 | -0.00 | -6731.67% | ▲5491369 |
| 2022-09-30 | 0.00 | -0.00 | -61645.36% | ▲917178 |
| 2022-06-30 | 0.00 | -0.00 | -70817.14% | ▼6073567 |
| 2022-03-31 | 0.00 | -0.00 | -10081.47% | ▲24926107 |
| 2021-12-31 | 0.00 | -0.01 | -259342.54% | ▼25798128 |
| 2021-09-30 | 0.00 | -0.00 | -1361.26% | ▼116786 |
| 2021-06-30 | 0.00 | -0.00 | -193.40% | ▼600 |
| 2021-03-31 | 0.00 | -0.00 | -187.40% | ▲52144 |
| 2020-12-31 | 0.00 | -0.00 | -708.85% | ▲107088 |
| 2020-09-30 | 0.00 | -0.00 | -1779.72% | ▼158760 |
| 2020-06-30 | 0.00 | -0.00 | -192.12% | ▲1005 |
| 2020-03-31 | 0.00 | -0.00 | -202.17% | ▼2320 |
| 2019-12-31 | 0.00 | -0.00 | -178.97% | ▲79540 |
| 2019-09-30 | 0.00 | -0.00 | -974.37% | ▲42993 |
| 2019-06-30 | 0.00 | -0.00 | -1404.30% | ▼111056 |
| 2019-03-31 | 0.00 | -0.00 | -293.75% | ▼19972 |
| 2018-12-31 | 0.00 | -0.00 | -94.02% | ▼7594 |
| 2018-03-31 | 0.00 | -0.00 | -18.08% | ▼2368 |
| 2017-12-31 | 0.00 | 0.00 | 5.60% | ▲8064 |
| 2017-03-31 | 0.00 | -0.00 | -75.05% | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.